Leukemic priming of resting NK cells is killer Ig-like receptor independent but requires CD15-mediated CD2 ligation and natural cytotoxicity receptors

Journal of Immunology

Volumn 187, Issue 12, 2011, Pages 6227-6234

  Sabry, May ^a   Tsirogianni, Maria ^a   Bakhsh, Ismail A ^a   North, Janet ^a   Sivakumaran, Janani ^a   Giannopoulos, Konstantinos ^a   Anderson, Robert ^a   Mackinnon, Stephen ^a   Lowdell, Mark W ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C TYPE LECTIN RECEPTOR; CD15 ANTIGEN; CD16 ANTIGEN; CD2 ANTIGEN; CD3 ANTIGEN; CD3ZETA ANTIGEN; GAMMA INTERFERON; HLA ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; LECTIN RECEPTOR; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR; STAT5 PROTEIN; UNCLASSIFIED DRUG;

ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; CANCER RESISTANCE; CONTROLLED STUDY; CRYOPRESERVATION; CYTOKINE PRODUCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LEUKEMIA CELL; LIGAND BINDING; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; RAJI CELL; T LYMPHOCYTE ACTIVATION; TUMOR CELL DESTRUCTION;

ANTIGENS, CD15; ANTIGENS, CD2; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL LINEAGE; COCULTURE TECHNIQUES; CYTOTOXICITY, IMMUNOLOGIC; DISEASE RESISTANCE; FUCOSYLTRANSFERASES; G0 PHASE; HUMANS; KILLER CELLS, NATURAL; LEUKEMIA, MONOCYTIC, ACUTE; LEUKEMIA, MYELOMONOCYTIC, ACUTE; LIGANDS; LYMPHOCYTE ACTIVATION; LYMPHOMA, NON-HODGKIN; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROTEIN BINDING; RECEPTORS, KIR; SIGNAL TRANSDUCTION;

EID: 83755196125     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101640     Document Type: Article

References (15)

1. Bryceson, Y. T., M. E. March, H.-G. Ljunggren, and E. O. Long. 2006. Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood 107: 159-166. (Pubitemid 43053538)
2. North, J., I. Bakhsh, C. Marden, H. Pittman, E. Addison, C. Navarrete, R. Anderson, and M. W. Lowdell. 2007. Tumor-primed human natural killer cells lyse NK-resistant tumor targets: evidence of a two-stage process in resting NK cell activation. J. Immunol. 178: 85-94. (Pubitemid 46033590)
3. x) on myeloid cells is a novel ligand for human CD2. J. Immunol. 156: 2866-2873.
4. Nakayama, F., S. Nishihara, H. Iwasaki, T. Kudo, R. Okubo, M. Kaneko, M. Nakamura, M. Karube, K. Sasaki, and H. Narimatsu. 2001. CD15 expression in mature granulocytes is determined by alpha 1,3-fucosyltransferase IX, but in promyelocytes and monocytes by alpha 1,3-fucosyltransferase IV. J. Biol. Chem. 276: 16100-16106.
5. Zufferey, R., D. Nagy, R. J. Mandel, L. Naldini, and D. Trono. 1997. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotechnol. 15: 871-875.
6. Chan, L., N. Hardwick, D. Darling, J. Galea-Lauri, J. Gaken, S. Devereux, M. Kemeny, G. Mufti, and F. Farzaneh. 2005. IL-2/B7.1 (CD80) fusagene transduction of AML blasts by a self-inactivating lentiviral vector stimulates T cell responses in vitro: a strategy to generate whole cell vaccines for AML. Mol. Ther. 11: 120-131. (Pubitemid 40012006)
7. McCann, F. E., P. Eissmann, B. Onfelt, R. Leung, and D. M. Davis. 2007. The activating NKG2D ligand MHC class I-related chain A transfers from target cells to NK cells in a manner that allows functional consequences. J. Immunol. 178: 3418-3426. (Pubitemid 46417606)
8. Lowdell, M. W., F. Shamim, M. Hamon, I. D. Macdonald, and H. G. Prentice. 1995. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation. Exp. Hematol. 23: 1530-1534. (Pubitemid 26035719)
9. dim/CD16+ NK-cell subset. Blood 116: 3865-3874.
10. Moingeon, P., J. L. Lucich, D. J. McConkey, F. Letourneur, B. Malissen, J. Kochan, H. C. Chang, H. R. Rodewald, and E. L. Reinherz. 1992. CD3 ζ dependence of the CD2 pathway of activation in T lymphocytes and natural killer cells. Proc. Natl. Acad. Sci. USA 89: 1492-1496.
11. Inoue, H., M. Miyaji, A. Kosugi, M. Nagafuku, T. Okazaki, T. Mimori, R. Amakawa, S. Fukuhara, N. Domae, E. T. Bloo, and H. Umehara. 2002. Lipid rafts as the signaling scaffold for NK cell activation: tyrosine phosphorylation and association of LAT with phosphatidylinositol 3-kinase and phospholipase C-gamma following CD2 stimulation. Eur. J. Immunol. 32: 2188-2198. (Pubitemid 34965881)
12. Gonsky, R., R. L. Deem, J. Bream, H. A. Young, and S. R. Targan. 2004. Enhancer role of STAT5 in CD2 activation of IFN-γ gene expression. J. Immunol. 173: 6241-6247. (Pubitemid 39487782)
13. Yu, T.-K., E. G. Caudell, C. Smid, and E. A. Grimm. 2000. IL-2 activation of NK cells: involvement of MKK1/2/ERK but not p38 kinase pathway. J. Immunol. 164: 6244-6251. (Pubitemid 30408804)
14. Ciccone, E., D. Pende, O. Viale, A. Than, C. Di Donato, A. M. Orengo, R. Biassoni, S. Verdiani, A. Amoroso, A. Moretta, and L. Moretta. 1992. Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2). J. Exp. Med. 176: 963-971.
15. Imai, K., S. Matsuyama, S. Miyake, K. Suga, and K. Nakachi. 2000. Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population. Lancet 356: 1795-1799.